MedTrace Logo

Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel

NCT05926557 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-05-24

No results posted yet for this study

Summary

The aim of the study is to evaluate the potential of a spermidine-based topical gel as an adjuvant to non-surgical treatment of peri-implant mucositis. After a meticulous selection, patients will be randomly assigned to Test (spermidine gel + non-surgical debridement) or Control group (non-surgical debridement).

Conditions

  • Peri-implant Mucositis
  • Mucositis Oral

Interventions

PROCEDURE

Spermidine gel

First step: Non-surgical mechanical debridement (NSMD) Second step: application of spermidine gel

PROCEDURE

NSMD

Only mechanical debridement with curettes and scaler peek tips

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926557 on ClinicalTrials.gov